4-butyrolactone has been researched along with Carcinoma, Epidermoid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JG; Hsu, SC; Huang, YP; Kuo, YH; Lin, ML; Yu, CC; Yu, FS | 1 |
| Bommareddy, A; Chen, W; Dwivedi, C; Fahmy, H; Hildreth, MB; Kaushik, RS; Khalifa, S; Zeman, D; Zhang, X | 1 |
| Aziz, RM; Carlton, PS; Chen, T; Dixit, R; Qin, H; Rose, ME; Stoner, GD | 1 |
1 review(s) available for 4-butyrolactone and Carcinoma, Epidermoid
| Article | Year |
|---|---|
gamma-Butyrolactone.
Topics: 4-Butyrolactone; Animals; Animals, Newborn; Carcinogens; Carcinoma, Squamous Cell; Drug Evaluation, Preclinical; Female; Food Analysis; Furans; Humans; Jaw Neoplasms; Lethal Dose 50; Male; Mice; Pituitary Neoplasms; Rats; Skin Neoplasms; Testicular Neoplasms | 1976 |
3 other study(ies) available for 4-butyrolactone and Carcinoma, Epidermoid
| Article | Year |
|---|---|
4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
Topics: 4-Butyrolactone; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Squamous Cell Carcinoma of Head and Neck | 2016 |
Chemopreventive effects of sarcophine-diol on ultraviolet B-induced skin tumor development in SKH-1 hairless mice.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Apoptosis; Body Weight; Carcinoma, Squamous Cell; Caspase 3; Caspase 8; DNA Fragmentation; Female; Gene Expression Regulation, Enzymologic; Mice; Mice, Hairless; Models, Animal; Neoplasms, Radiation-Induced; Skin Neoplasms; Ultraviolet Rays | 2009 |
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dimethylnitrosamine; Dinoprostone; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Male; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; RNA, Messenger; Sulfones | 2005 |